共 50 条
Left main coronary artery disease: when and how to perform PCI?
被引:5
|作者:
Chiarito, Mauro
[1
,2
]
Mehilli, Julinda
[3
,4
]
机构:
[1] Humanitas Res Hosp, Cardio Ctr, Milan, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Ludwig Maximilians Univ Munchen, Munich Univ Hosp, Dept Cardiol, Munich, Germany
[4] Gemian Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany
来源:
MINERVA CARDIOANGIOLOGICA
|
2020年
/
68卷
/
05期
关键词:
Coronary artery disease;
Percutaneous coronary intervention;
Drug-eluting stents;
Coronary artery bypass;
DRUG-ELUTING STENT;
INTRAVASCULAR ULTRASOUND GUIDANCE;
LONG-TERM OUTCOMES;
BYPASS-SURGERY;
BIFURCATION LESIONS;
FOLLOW-UP;
EXPANSION CAPACITY;
RANDOMIZED-TRIAL;
5-YEAR OUTCOMES;
DELTA REGISTRY;
D O I:
10.23736/S0026-4725.20.05198-1
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Left main coronary artery (LMCA) disease has been reported in up to 10% of all patients with coronary artery disease (CAD) and in the majority of cases are associated with severe three-vessel CAD. Among patients with chronic coronary syndrome revascularization of significant LMCA disease improves prognosis, while there is a debate about which revascularization strategy, CABG surgery or percutaneous coronary interventions to use. We do a review of the available evidence about the impact of LMCA lesions on patient prognosis according to CAD extension and clinical presentation, the outcome after percutaneous or surgical revascularization, the procedural challenges of LMCA PCI and the available armamentarium to optimally treat this relevant population.
引用
收藏
页码:405 / 414
页数:10
相关论文